Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

GTx initiates phase II trial of enobosarm for stress urinary incontinence

Jan. 14, 2016

Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve

Jan. 14, 2016

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Jan. 7, 2016

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors

Dec. 22, 2015

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Dec. 15, 2015

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

BTK inhibition, a potential strategy for the treatment of lupus nephritis

Nov. 26, 2015

Angion's CYP11B2 inhibitor shows potential for CKD in animal models

Nov. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...